Home > Insider Trading > Filing (0001560637-18-000001)

Filing Details

Accession Number:: 0001560637-18-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-04-11 15:51:22
Reporting Period:: 2017-09-07

Accepted Time:: 2018-04-11 15:51:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949721	Meridian Waste Solutions Inc.	MRDN	Sanitary Services (4950)	133832215

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1560637	A Clayton Struve	175 W Jackson Blvd Suite 440 Chicago IL 60604		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.025 Per Share	Acquisiton	2017-07-27	20,389	$0.00	1,141,161	No	4	P	Direct
Common Stock, Par Value $0.025 Per Share	Acquisiton	2017-09-07	353,766	$0.00	1,494,927	No	4	P	Direct
Common Stock, Par Value $0.025 Per Share	Acquisiton	2017-10-17	220,000	$0.00	1,714,927	No	4	P	Direct
Common Stock, Par Value $0.025 Per Share	Acquisiton	2017-11-17	80,000	$0.00	1,794,927	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series D Preferred Stock, par value $0.001 per share	Acquisiton	2017-09-07	97,850	$0.00	978,500	$1.00
Common Stock	Warrants to Purchase Common Stock	Acquisiton	2017-09-07	1,467,750	$0.00	1,467,750	$1.44
Common Stock	Series E Preferred Stock, par value $0.001 per share	Acquisiton	2017-10-17	110,000	$0.00	1,100,000	$1.00
Common Stock	Warrants to Purchase Common Stock	Acquisiton	2017-10-17	1,650,000	$0.00	1,650,000	$1.20
Common Stock	Series E Preferred Stock, par value $0.001 per share	Acquisiton	2017-11-17	40,000	$0.00	400,000	$1.00
Common Stock	Warrants to Purchase Common Stock	Acquisiton	2017-11-17	600,000	$0.00	600,000	$1.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
181,598	2017-09-07		No	4	P	Direct
181,598	2018-03-08	2022-09-07	No	4	P	Direct
181,598	2017-09-07		No	4	P	Direct
181,598	2018-04-18	2022-10-17	No	4	P	Direct
181,598	2018-01-10		No	4	P	Direct
181,598	2018-05-18	2022-11-17	No	4	P	Direct

Footnotes

1. As of July 27, 2017, 20,389 shares of were issued as dividends for the shares of Series C Preferred Stock owned by the Reporting Person, earned prior to the date of the automatic conversion of all shares of Series C Preferred Stock.
As of September 7, 2017, in connection with the Issuer's private placement offering, the Reporting Person purchased an aggregate of 97,850 Units at a price of $10.00 per Unit, with each Unit consisting of one share of the Company's Series D Preferred Stock, three shares of the Issuer's Common Stock and 15 Warrants to purchase the Issuer's Common Stock with an exercise price of $1.44 per share exercisable beginning 6 months after the date of issuance and within 5 years from the date of issuance. Each share of Series D Preferred Stock has a stated value of $10.00 and can be converted into shares of the Issuer's Common Stock at the price of $1.00 per share of Common Stock. Additional shares of Common Stock were issued at closing as dividends for the first year, issued in advance, at the rate of 8% per annum, based on a share price of $1.30. There is no expiration date for conversion of the Series D Preferred Stock.
. Does not include 978,500 shares of common stock into which such stockholder's shares of Series D Preferred are convertible, because such conversion is restricted pursuant to the terms of the Series D Preferred designations, which prohibit conversions that would result in the holder owning greater than 4.99% of the Company's issued and outstanding common stock, unless waived upon 60 days' notice, but shall in no event exceed 19.99%, of the Company's issued and outstanding common stock. Does not include 1,467,500 shares of common stock issuable upon such stockholder's exercise of warrants, because such issuance is restricted pursuant to the terms such warrants, which prohibit conversions that would result in the holder owning greater than 4.99% of the Company's issued and outstanding common stock, unless waived upon 60 days' notice, but shall in no event exceed 19.99%, of the Company's issued and outstanding common stock. Such warrants are exercisable beginning March 8, 2018.
Between October 17, 2017 and November 17, 2017, in connection with the Company's private placement offering, the Reporting Person purchased an aggregate of 150,000 Units at a price of $10.00 per Unit, each Unit consisting of one share of the Company's Series E Convertible Preferred Stock and 15 Warrants to purchase the Company's Common Stock with an exercise price of $1.20 per share exercisable beginning 6 months after the date of issuance and within 5 years from the date of issuance. Additional shares of Common Stock were issued on January 10, 2018, upon effectiveness of approval of the Company's shareholders, as dividends for the first year, issued in advance, at the rate of 20% per annum, based on a share price of $1.00. There is no expiration date for conversion of the Series E Preferred Stock.
Does not include 1,500,000 shares of common stock into which such stockholder's shares of Series E Preferred are convertible, because the Series E Preferred prohibits conversions that would result in the holder owning greater than 4.99% of the Company's issued and outstanding common stock, unless waived upon 60 days' notice, but shall in no event exceed 19.99%, of the Company's issued and outstanding common stock. Does not include 2,250,000 shares of common stock issuable upon such stockholder's exercise of warrants, because such warrants prohibit exercises that would result in the holder owning greater than 4.99% of the Company's issued and outstanding common stock, unless waived upon 60 days' notice, but shall in no event exceed 19.99%, of the Company's issued and outstanding common stock. 1,650,000 of such warrants are exercisable beginning April 18, 2018; 600,000 of such warrants are exercisable beginning May 18, 2018.